Drug profile

The FDA adverse-event record for Liquid Dish Soap

180 FDA reports name Liquid Dish Soap, a high-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#565 of 2,679
by report volume (all drugs)
180
adverse-event reports
8.9%
death-coded share
Dog
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Liquid Dish Soap ranks #565 of 2679 by total reports (180) and #602 of 1130 by death-coded share (8.9%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#565
This drug, reports of 2679
#602
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Liquid Dish Soap has 180 reports now versus 180 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Liquid Dish Soap changes

Signature read: 180 reports place Liquid Dish Soap in the upper third of FDA AER volume (#565 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
180
Total Reports
16
Deaths Reported
8.9%
Death-coded share of reports

Active Ingredients

Liquid Dish Soap

Administration Routes

TopicalUnknownOral

Species Affected

Dog 102
Cat 76
Human 2

Most Affected Breeds

Domestic Shorthair 37
Dog (unknown) 16
Siamese 9
Domestic Mediumhair 9
Chihuahua 9
Cat (unknown) 9
Shih Tzu 5
Pit Bull 5
Shepherd Dog - German 5
Spitz - German Pomeranian 4

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 102
Drug dose administration interval too long 18
Lethargy (see also Central nervous system depression in 'Neurological') 16
Pruritus 15
Ataxia 15
Behavioural disorder NOS 14
Hypersalivation 13
Anorexia 11
Vomiting 10
Death 10
Seizure NOS 9
Hyperactivity 8

Outcome Breakdown

Outcome Unknown
141 (78.3%)
Recovered/Normal
17 (9.4%)
Died
11 (6.1%)
Ongoing
6 (3.3%)
Euthanized
5 (2.8%)

Liquid Dish Soap: high report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

High-volume nationwide drug peers

Two openFDA-derived peer sets for Liquid Dish Soap, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Liquid Dish Soap (#565 of 2,679 by report volume); death-coded 8.9%. PlainBreed drug row · report volume stamp 180 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →